Lily Dara MD

Dr. Lily Dara is an NIH-funded physician-scientist and clinician. She completed her Gastroenterology training at USC, is board-certified in Internal Medicine and Gastroenterology, and practices primarily as a hepatologist (liver specialist). Her clinical work is focused on autoimmune liver diseases such as Autoimmune Hepatitis (AIH) and Primary Biliary Cholangitis (PBC) and their variant syndromes.

She is currently practicing at the Los Angeles General Medical Center where she sees patients with liver disease (including alcohol-associated liver disease, fatty liver disease, viral hepatitis, liver failure, cirrhosis of the liver, drug-induced liver disease, metabolic and genetic disorders of the liver among many others) on the inpatient liver service and in the subspeciality liver clinics. At the Keck Hospital of USC, she performs procedures such as endoscopies and colonoscopies in the new outpatient endoscopy unit.

Her research focuses on disorders of the liver including drug-induced liver injury and hepatotoxicity from medications, drugs, toxins, and herbal supplements in translational animal models as well as humans. She participates as an investigator on the NIH’s Drug Induced Liver Injury Network (DILIN) and is a reviewer for the LiverTox website. Additionally, she studies Autoimmune Hepatitis and PBC outcomes in patients with a focus on understanding the impact of ace and ethnicity, in particular Hispanic/Latinx ethnicity on outcomes.